Basics Standard BioTools Inc. IPO Date: March 1, 2011 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $372.08M Activated in VL: True Average Daily Range Avg Daily Range: $0.07 | 3.58% Avg Daily Range (30 D): $0.05 | 4.45% Avg Daily Range (90 D): $0.05 | 4.00% Institutional Daily Volume Avg Daily Volume: .25M Avg Daily Volume (30 D): 1.03M Avg Daily Volume (90 D): 1.42M Trade Size Avg Trade Size (Sh.): 185 Avg Trade Size (Sh.) (30 D): 203 Avg Trade Size (Sh.) (90 D): 235 Institutional Trades Total Inst.Trades: 113 Avg Inst. Trade: $1.87M Avg Inst. Trade (30 D): $4.22M Avg Inst. Trade (90 D): $2.69M Avg Inst. Trade Volume: .95M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.17M Avg Closing Trade (30 D): $.88M Avg Closing Trade (90 D): $.88M Avg Closing Volume: 1.67M         News Apr 22, 2025 @ 11:00 AM Standard BioTools Schedules First Quarter Earnings... Source: N/A Jan 13, 2025 @ 12:00 PM Standard BioTools Announces Preliminary Fourth Qua... Source: N/A Dec 19, 2024 @ 1:00 PM Standard BioTools to Present at the 43rd Annual J.... Source: N/A Nov 7, 2024 @ 1:00 PM Standard BioTools Appoints Alex Kim as Chief Finan... Source: Standard Biotools Inc. Oct 16, 2024 @ 12:00 PM Standard BioTools Announces Conference Call and We... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-.07 $-.08 $-.52 Diluted EPS $-.07 $-.08 $-.52 Revenue $ 40.8M $ 46.72M $ 174.43M Gross Profit $ 19.74M $ 21.91M $ 84.26M Net Income / Loss $ -26.03M $ -34.07M $ -138.89M Operating Income / Loss $ -32.97M $ -32.82M $ -175.24M Cost of Revenue $ 21.05M $ 24.81M $ 90.17M Net Cash Flow $ -15.35M $ -43.12M $ 116.32M PE Ratio